Breadcrumbs Home News & Events Press Releases Press Releases Year All2026202520242023202220212020201920182017201620152014201320122011201020092008 Type AllRegulatoryNon-regulatory Jun 23, 2020 BioInvent enrolls first patient in Phase I/IIa trial of BI-1206 in combination with KEYTRUDA[®] for the treatment of patients with solid tumors Jun 22, 2020 BioInvent presents proof-of-concept data for two TNFR2-targeting antibodies Jun 22, 2020 BioInvent and Transgene's BT-001 achieves outstanding tumor cure rates in preclinical models Jun 18, 2020 Proposal for a new Board member to be elected at the Extraordinary General Meeting on July 3, 2020 Jun 09, 2020 Notice to Extraordinary General Meeting in BioInvent International AB Jun 09, 2020 BioInvent successfully completes a directed share issue of approximately SEK 487 million (approximately EUR 47 million) Pagination First page Previous page … Page 37 Current page 38 Page 39 Page 40 … Next page Last page
